ライフサイエンスコーパス: clonidine

1 2A and alpha2C, and the 125I-labeled agonist clonidine.

2 normoxic, hypoxic, and hypoxic-treated with clonidine.

3 rawal treatment with either buprenorphine or clonidine.

4 d by the selective alpha2 adrenergic agonist clonidine.

5 dose-dependently by perineural injection of clonidine.

6 intraarterial infusions of phenylephrine and clonidine.

7 agonist phenylephrine and the alpha2-agonist clonidine.

8 increased resistance to M. avium induced by clonidine.

9 sed resistance to M. avium growth induced by clonidine.

10 Pertussis toxin blocked the effect of clonidine.

11 role in the analgesic effect of intrathecal clonidine.

12 mediates the analgesic effect of intrathecal clonidine.

13 thoroughly the neuroprotective properties of clonidine.

14 idine orally; or combined nitroglycerin plus clonidine.

15 was not reduced by peripheral or intra-BSTv clonidine.

16 dies provided data for midazolam and two for clonidine.

17 ll as the adrenergic alpha2 receptor agonist clonidine.

18 Clonidine (0.003-0.1 mg/kg, i.p.) dose-dependently atten

19 he intracerebroventricular (ICV) infusion of clonidine (0.03 microgram) caused an increase in NO conc

20 hibited by pretreatment with a fixed dose of clonidine (0.15 mg/kg, s.c.).

21 , patients were randomly assigned to receive clonidine (0.2 mg per day) or placebo just before surger

22 uring iontophoresis of phenylephrine (PE) or clonidine (0.5 mm, seven 0.1 mA pulses followed by one 0

23 interval [CI], -1.70 to -0.57), 4 trials of clonidine (-0.95; 95% CI, -1.44 to -0.47), and 2 trials

24 Oral clonidine, 0.1 mg/d, is effective against tamoxifen-indu

25 Sheep were treated with clonidine (1 mug/kg/hr) or saline-vehicle from 24 to 32

26 cardiac rate, followed by administration of clonidine (1.0 mg/kg).

27 Nanoinjection of the alpha2-AR agonist clonidine (1.2 nmol) into the rostral raphe pallidus are

28 367 and 339, respectively; hazard ratio with clonidine, 1.08; 95% confidence interval [CI], 0.93 to 1

29 Furthermore, the general alpha2-AR agonist clonidine (10 muM) failed to affect sIPSC frequency.

30 onists dexmedetomidine (25 mug/kg, i.v.) and clonidine (100 mug/kg, i.v.) inhibited shivering EMGs, B

31 nylephrine (-11 +/- 4 versus -39 +/- 4%) and clonidine (-12 +/- 4 versus -38 +/- 5%; all P < 0.005) w

32 enylephrine (-3 +/- 3 versus -28 +/- 4%) and clonidine (-15 +/- 4 versus -26 +/- 3%; all P < 0.05).

33 henylephrine (-12 +/- 8 vs. -37 +/- 8 %) and clonidine (-17 +/- 6 vs. -49 +/- 4 %) were significantly

34 lysaccharide, 10.7 [95% CI, 9.9-11.6]; after clonidine, 17.5 [95% CI, 16.7-18.4]).

35 thylphenidate (11.1); antidepressants (3.2); clonidine (2.3); and neuroleptics (0.9).

36 saline, dexmedetomidine (100 mug/kg IV), or clonidine (200 mug/kg IV).

37 tly studied and efficacious medications were clonidine (22 studies; risk ratio: 1.6, numbers needed t

38 older men, but did attenuate the response to clonidine (-22 +/- 3 versus -37 +/- 6%; P < 0.05).

39 Conscious rats received saline, clonidine (30 microg/kg, i.v.), saline plus sodium nitro

40 eatment (72%) relative to those who received clonidine (39%) (P<.05).

41 iglets that were in the Hx+Cl group received clonidine 5 min prior to hypoxia.

42 In vitro stimulation of the NTS with clonidine (50 nmol/L) resulted in an increase in the NO

43 pants choosing naltrexone therapy within the clonidine (8 [22.2%]), tramadol ER (7 [19.4%]), or bupre

44 Clonidine, a readily available medication, is useful in

45 In contrast, clonidine-activated alpha(2A)AR were switched by voltage

46 , studies were designed to ascertain whether clonidine acts as a free radical scavenger.

47 These results suggest that pre-operative clonidine administration could be a useful supplement to

48 the present study tests the hypothesis that clonidine administration will block increased nuclear Ca

49 After clonidine administration, growth hormone rose in PSP sub

50 Clonidine alone had no effect, but when administered fol

51 o G protein is more readily achieved for the clonidine/alpha(2)-AR/Goalpha1 complex.

52 release), phenylephrine (alpha1-agonist) and clonidine (alpha2-agonist) were assessed.

53 henylephrine (selective alpha1-agonist), and clonidine (alpha2-agonist) were determined in 10 young (

54 ether the increase in decisiveness driven by clonidine also entails changes in hippocampal search pro

55 Clonidine also increased the production of ONOO(-) in M.

56 Clonidine also induced lower levels of NE release in the

57 Systemic clonidine also prevented the stress-associated increase

58 tions in the LH of two inhibitory compounds, clonidine (an alpha-2 adrenergic agonist) and muscimol (

59 ease), phenylephrine (an alpha1 agonist) and clonidine (an alpha2 agonist) in 10 healthy men during r

60 This study tests whether clonidine, an alpha(2)-adrenergic receptor agonist, alte

61 These effects were all mimicked by clonidine, an alpha-2 receptor agonist.

62 , including peripheral nerve block or spinal clonidine, an alpha2-adrenergic agonist.

63 Significance statement: Clonidine, an alpha2-adrenergic receptor agonist, which

64 ns had a higher spontaneous firing rate, and clonidine-an alpha2A-adrenergic agonist-inhibited LC neu

65 w, medium, and high renin, respectively, for clonidine and 83%, 82%, and 83%, respectively, for dilti

66 he effect of noradrenaline was reproduced by clonidine and antagonized by yohimbine, consistent with

67 -dependent adolescents relative to combining clonidine and behavioral interventions.

68 vitro data were generally in agreement that clonidine and bFGF counteracted the effect of NMDA as wo

69 gest that tramadol ER is more effective than clonidine and comparable to buprenorphine in reducing op

70 Clonidine and dexmedetomidine have many similar or super

71 Clonidine and diltiazem had consistent response rates re

72 in native sympathetic neurons in response to clonidine and guanfacine, two drugs used for treatment o

73 occurred in 329 patients (6.6%) assigned to clonidine and in 295 patients (5.9%) assigned to placebo

74 opioids as adjuncts are being challenged by clonidine and ketamine, which have more benign side effe

75 Clonidine and nitroglycerin increased gastric compliance

76 amines and diphenhydramine; second, miosis - clonidine and opioids; third, nystagmus - dextromethorph

77 scending doses of oral naltrexone along with clonidine and other adjunctive medications.

78 ommonly experienced by patients treated with clonidine and other imidazoline-related drugs.

79 is necessary for the hypotensive effects of clonidine and other sympathoinhibitory adrenergic agonis

80 Thus, clonidine and oxymetazoline behaved as partial agonists.

81 Gialpha1 increased the relative efficacy of clonidine and oxymetazoline such that the two ligands no

82 The alpha agonists clonidine and phenylephrine both inhibited the potassium

83 In 16 other healthy subjects, the effects of clonidine and placebo on gastric emptying of solids were

84 y acting alpha2-adrenergic receptor agonist, clonidine), and hypoxia and sympathetic inhibition.Oxyha

85 honium, procaine, phencyclidine, cocaine, or clonidine), and the peptides displayed enhanced selectiv

86 g sedative premedications such as midazolam, clonidine, and dexmedetomidine.

87 The SSRIs or SNRIs, clonidine, and gabapentin trials provide evidence for ef

88 sed to treat vasovagal syncope (propranolol, clonidine, and paroxetine) in a double-blind crossover s

89 ing exercise and is reversed by propranolol, clonidine, and paroxetine.

90 f ethanol, oxotremorine, nicotine, baclofen, clonidine, and the cannabinoid receptor agonist WIN 55,2

91 Since this treatment completely antagonized clonidine antinociception (40 microg, i.c.v.), supraspin

92 2 channels in mutant mice largely eliminated clonidine antinociception and significantly decreased mo

93 The protective effect of 0.5% clonidine appeared to be greater when topically applied

94 8-day-old rats whether these 2 responses to clonidine are causally related.

95 Alpha-2 adrenoceptor agonists (e.g., clonidine) are effective at preventing many of the behav

96 ties of alpha(2)-adrenoceptor agonists, like clonidine, are very different from betaxolol.

97 a cellular substrate for the clinical use of clonidine as a treatment for hypertension as well as a r

98 likely that the use of epidural ketamine or clonidine as adjuncts to local anaesthetics will grow.

99 Clonidine, as compared with placebo, did not reduce the

100 Clonidine, as compared with placebo, was associated with

101 .1.1.28) and as inhibitors of the binding of clonidine at the alpha(2)-adrenoceptor.

102 e (PNMT) and as inhibitors of the binding of clonidine at the alpha(2)-adrenoceptor.

103 injection of the alpha2-adrenoceptor agonist clonidine at the site of peripheral nerve injury reduces

104 alpha(2)-adrenoceptor agonists, such as clonidine, attenuate hypoxia-induced damage to brain and

105 Clonidine attenuated the increases in c-fos in the mNTS

106 Low-dose clonidine attenuates sympathetic outflow and systemic in

107 action, and provide the first evidence that clonidine attenuates the expression of the closely linke

108 he presence and absence of a alpha2-agonist (clonidine), beta-adrenergic receptor antagonist (propran

109 ailed to show displacement of specific [(3)H]clonidine binding to rat brain membranes for either comp

110 The authors tested whether clonidine blocks stress-induced seeking of heroin and co

111 The fact that both betaxolol and clonidine blunt hypoxia-induced death to retinal ganglio

112 Clonidine but not nitroglycerin reduced aggregate and pa

113 with oestrogen, gabapentin, paroxetine, and clonidine, but little or no benefit with other agents; a

114 Moreover, i.p. injection of clonidine, but not betaxolol, elevated bFGF mRNA levels

115 em to mediate the antinociceptive effects of clonidine, but not that produced by improgan.

116 Statins, beta-blockers, and clonidine can potentially improve long-term cardiac risk

117 Administration of perioperative clonidine can reduce the risk of perioperative myocardia

118 This ICV injection of clonidine caused a fall in mean arterial pressure of -22

119 rgic agonists (phenylephrine (PE), alpha(1); clonidine (CL), alpha(2)).

120 deltorphin II (DELT), the alpha(2)AR agonist clonidine (CLON) or their combination to inhibit calcito

121 Clonidine (CLON), an alpha-2 agonist, has anxiolytic-lik

122 0.5 mg/kg BW), an alpha2-adrenergic agonist, clonidine (CLON; 0.6 mg/kg BW), or a beta-adrenergic ago

123 microinfusions (1 mul) of the alpha2 agonist clonidine (CLON; 1.32 nmol), and half received the alpha

124 Perioperative clonidine comes in a patch form that can be used in pati

125 nists such as oxymetazoline, cirazoline, and clonidine, confirming previous evidence that this class

126 ine and synaptic transmission was reduced by clonidine, consistent with an action at presynaptic alph

127 ulation of the release of NO in the brain by clonidine contributes to its central antihypertensive ac

128 thesized that the anxiolytic-like actions of clonidine could be mimicked by stimulation of alpha-2 re

129 NE and clonidine decreased calcium currents evoked by depolariz

130 The roles of clonidine, dexmedetomidine, ketamine and nalbuphine in t

131 Clonidine did not affect basal [(3)H]cAMP levels, but at

132 Although NO production was required, clonidine did not increase the level of NO in M. avium-i

133 s: hydrochlorothiazide, atenolol, captopril, clonidine, diltiazem (sustained release), or prazosin.

134 ous ligand(s) for imidazoline binding sites, clonidine-displacing substance (CDS), has been a major g

135 Administration of clonidine during hypotensive sepsis reduced renal sympat

136 or antagonists (atropine and scopolamine) on clonidine-elicited nitrite release was more potent than

137 inic antagonists dose-dependently attenuated clonidine-elicited nitrite release.

138 Clonidine evoked a decrease in cRCF ( approximately 30%;

139 Clonidine evoked both increases and decreases in cRCF be

140 idazoxan (6 nmol) into the rRPa reversed the clonidine-evoked inhibition of BAT SNA and BAT thermogen

141 arinic and nicotinic receptor antagonists on clonidine-evoked nitrite (a stable product of NO) releas

142 e present study, we tested a hypothesis that clonidine-evoked NO release is dependent primarily on mu

143 Ineffective drugs included clonidine, flunarizine, pizotifen, propranolol, and valp

144 dition, iontophoresis of the alpha-2 agonist clonidine, footshock administration, and LC stimulation

145 s before the clonidine) reduced responses to clonidine for both mean arterial pressure and heart rate

146 nd epidural ones, as well as the addition of clonidine for peripheral neural blockade, have been desc

147 have shown certain benefits from the use of clonidine for regional anesthesia, further investigation

148 Most authors agree that the use of clonidine for regional neural blockade in combination wi

149 itch was notably faster than dissociation of clonidine from alpha(2A)AR, indicating voltage-dependent

150 in quality-of-life scores (0.3 points in the clonidine group compared with -0.2 points in the placebo

151 During intervention, the clonidine group had a lower number of steps per day (mea

152 prenorphine condition and 5% of those in the clonidine group initiated treatment with naltrexone.

153 se in hot flash frequency was greater in the clonidine group than in the placebo group after 4 weeks

154 Significantly more patients in the clonidine group than in the placebo group had clinically

155 group difference in time to relapse, but the clonidine group took longer to lapse (hazard ratio=0.67,

156 partly decoupled from opioid craving in the clonidine group, supporting the authors' hypothesized me

157 Propranolol and clonidine had no significant effect on SBP during exerci

158 Background- Clonidine has an antihypertensive effect by its action i

159 Clonidine has been used for many purposes, including red

160 Clonidine has recently been used as a pre-operative medi

161 re therefore undertaken to determine whether clonidine has similar properties.

162 Perioperative clonidine has some advantages over perioperative beta-bl

163 Clonidine hydrochloride capsules (25 microg or 50 microg

164 Oral clonidine hydrochloride, 0.1 mg/d, or placebo for 8 week

165 Administration of low-dose clonidine in patients undergoing noncardiac surgery did

166 The latest articles describing the use of clonidine in regional anesthesia are discussed.

167 dazol-2-yl)-6-quinoxalinamine (UK14,304) and clonidine in spinophilin-null mice.

168 The increased efficacy observed for clonidine in the Goalpha1 transfectants was not due to c

169 se findings, a clinical trial for the use of clonidine in the treatment of persistent vasopressor-ref

170 effect of the alpha(2)-adrenoceptor agonist clonidine in this rat model.

171 BB NHE3 exists in lipid rafts; (ii) EGF and clonidine increase the amount of BB NHE3; (iii) lipid ra

172 mans, the alpha2-adrenergic receptor agonist clonidine increases decisiveness in tasks that require p

173 Prolonged treatment with either DAMGO or clonidine induced a mutual cross-desensitization between

174 pha(2)-adrenergic agonist (alpha(2)-agonist) clonidine induced resistance to M. avium growth in the R

175 uble NHE3 pool, are involved in the EGF- and clonidine-induced acute increase in amount of BB NHE3; (

176 Clonidine-induced alpha(2A)AR desensitization, but not r

177 urthermore, the more pronounced morphine and clonidine-induced antinociception in male mice disappear

178 Based on the almost complete loss of clonidine-induced antinociception in the mutant mice, we

179 This EGF- and clonidine-induced increase of BB NHE3 was associated wit

180 nic, as well as nicotinic, receptors mediate clonidine-induced NO release in the spinal cord.

181 ce has indicated that a key mechanism of the clonidine-induced reversal of the effects of NMDA antago

182 Prenalterol pretreatment suppressed clonidine-induced ultrasound production at both doses.

183 2 mild hyperthermia significantly inhibited clonidine-induced ultrasound production.

184 Noradrenaline or clonidine inhibited the capsaicin-activated current by a

185 ol5]enkephalin (DAMGO) or the alpha2 agonist clonidine inhibited voltage-gated Ca2+ currents in these

186 ese findings establish a causal link between clonidine inhibition of c-fos expression in brainstem an

187 No evidence could be found that clonidine interacts with sodium or L-type calcium channe

188 Clonidine is a partial alpha 2 adrenergic agonist that h

189 When clonidine is added to a fentanyl-bupivacaine mixture for

190 lts suggest that the decisiveness seen under clonidine is due to limited exploration of potential opt

191 logues of the alpha2 adrenergic agonist drug clonidine is elaborated.

192 Low-dose clonidine is not clinically useful in CFS.

193 ion of alpha(2) adrenergic agonists, such as clonidine, is capable of alleviating neuropathic pain.

194 egy is to combine adjuvants such as opioids, clonidine, ketamine and neostigmine to potentiate the ef

195 Researchers have speculated that clonidine limits the amount of mental search that subjec

196 We find that clonidine limits the options searched by rats, suggestin

197 However, the mechanisms by which clonidine makes them more decisive remain unknown.

198 Yohimbine antagonized the clonidine-mediated adenylyl cyclase inhibition.

199 H enhanced the alpha2-adrenoreceptor agonist clonidine-mediated inhibition (3 microM; NORM, 23 +/- 2%

200 he presence of the NO donor spermine-NO, the clonidine-mediated inhibition of forskolin- and isoprote

201 Clonidine, meperidine, tramadol, nefopam, and ketamine w

202 lammatory agents, anticonvulsants, ketamine, clonidine, mexiletine, antidepressants, and anxiolytics

203 cerebroventricularly applied agonists (NMDA, clonidine, muscimol, and baclofen) at several types of r

204 A 7-day taper using clonidine (n = 36), tramadol ER (n = 36), or buprenorphi

205 angiotensin-converting-enzyme inhibitors, or clonidine (n=15,044), those assigned calcium antagonists

206 prenorphine and randomly assigned to receive clonidine (N=61) or placebo (N=57) for 14 weeks.

207 ase alpha2-adrenergic agonists guanfacine or clonidine (no studies).

208 nts 1 and 2 prevent or dampen the effects of clonidine on cardiac rate.

209 cavenger of ONOO(-), inhibited the effect of clonidine on M. avium growth.

210 the effects of the alpha2-adrenergic agonist clonidine on mean arterial pressure, renal sympathetic n

211 role in the analgesic effect of intrathecal clonidine on neuropathic pain.

212 search processes, we compared the effect of clonidine on spatial representations in hippocampal neur

213 The present study investigated the effect of clonidine on the basal and inducible c-jun and c-fos mRN

214 Studies of the effects of clonidine on these gastric functions and symptoms in dis

215 aken to determine whether i.p. injections of clonidine or betaxolol affect retinal bFGF mRNA levels.

216 awal (ie, detoxification) from opioids using clonidine or buprenorphine hydrochloride is a widely use

217 Here, we test this hypothesis using clonidine or guanfacine (GFC), another alpha-2 agonist,

218 In contrast, the adrenergic agonists clonidine or norepinephrine, and the K(ATP) channel inhi

219 re randomized 1:1 to treatment with low-dose clonidine or placebo for 9 weeks and monitored for 30 we

220 plications to receive aspirin or placebo and clonidine or placebo.

221 nous nitroglycerin; 0.0125, 0.025, or 0.1 mg clonidine orally; or combined nitroglycerin plus clonidi

222 ipants, surgeons, and sedationists preferred clonidine over the placebo.

223 (AR) transfectants, the alpha(2)-AR agonists clonidine, oxymetazoline, UK-14304, and epinephrine incr

224 tained at the end of the taper compared with clonidine participants (22 [61.1%]); tramadol ER retenti

225 isfaction in the group of patients receiving clonidine plus morphine.

226 ), saline plus sodium nitroprusside (NP), or clonidine plus NP.

227 tment (0.03-0.15 mg/kg, s.c.) and reduced by clonidine posttreatment (0.15 mg/kg, s.c.).

228 Clonidine pre-treatment increased and prolonged sedation

229 trial, we characterized the effects of oral clonidine pre-treatment on intravenous diazepam/meperidi

230 s also inhibited in a dose-related manner by clonidine pretreatment (0.03-0.15 mg/kg, s.c.) and reduc

231 Perineural clonidine prevented both the increase in leukocyte numbe

232 creased with hypoxia (137 +/- 13%; P =0.02); clonidine prevented the hypoxia induced increase (94 +/-

233 The data show that clonidine prevents hypoxia-induced increase in CaM KIV a

234 In an intent-to-treat analysis, clonidine produced the longest duration (in consecutive

235 suggest that while most of topically applied clonidine reaches the retina by a systemic route one can

236 rgic (phenylephrine) and alpha 2-adrenergic (clonidine) receptor stimulation were blunted during mode

237 d opioid (morphine) and alpha(2)-adrenergic (clonidine) receptor-induced antinociception in a spinal

238 Additionally, clonidine reduced the capacity of leukocytes to express

239 Similarly, clonidine reduced the frequency of capsaicin-induced mEP

240 In spinal cord slices, clonidine reduced the frequency of capsaicin-induced min

241 Clonidine reduced the number of macrophages and lymphocy

242 cromol; delivered ICV, 30 minutes before the clonidine) reduced responses to clonidine for both mean

243 ne, ketamine, dexmedetomidine, propofol, and clonidine) reduced the risk of delirium (relative risk,

244 nd the alpha(2)-adrenergic receptor agonist, clonidine, reduced the number of Fos-li dopaminergic neu

245 ngs should be reconciled with the absence of clonidine-related GH blunting in the same cohort.

246 Clonidine relaxes the stomach and reduces gastric sensat

247 activation of adrenergic alpha2 receptors by clonidine represents a double-hit to pancreatic islets t

248 determine whether the hypotensive action of clonidine resulted from its stimulation of excess NO in

249 of patients' stress to test hypotheses about clonidine's behavioral mechanism of action.

250 ting the authors' hypothesized mechanism for clonidine's benefits.

251 These results suggest that clonidine's effect on ultrasound production is mediated

252 Clonidine significantly increased the numbers of BIS-dep

253 Clonidine significantly inhibited GABAergic neurotransmi

254 ising for the treatment of gastroparesis are clonidine, sildenafil, and intrapyloric botulinum toxin.

255 istration of the alpha2 adrenoceptor agonist clonidine simultaneously evokes ultrasound production an

256 e include a belladonna alkaloid preparation, clonidine, soy phyto-oestrogens, vitamin E, gabapentin,

257 P < .001) from stabilization to taper in the clonidine (stabilization mean, 0.64 [SE, .05]; taper mea

258 between 1991 and 1995 across the 3 sites for clonidine, stimulants, and antidepressants, while neurol

259 Injection of clonidine suppressed the spatial representation of the u

260 between the taper and post-taper periods for clonidine (taper mean, 13.1; post-taper mean, 3.2; P < .

261 The response to growth hormone-clonidine testing, a neuropharmacological assessment of

262 ogram, while the HMO had nearly 3 times more clonidine than antidepressant use (1.9 vs 0.7).

263 ion and endocytosis of alpha(2A)AR evoked by clonidine than by guanfacine.

264 nsitization of Ca(2+) current suppression by clonidine than guanfacine, which paralleled a more marke

265 dentified a second-line agent, perioperative clonidine, that can be used to reduce the risk of periop

266 r harmane, the alpha(2)-adrenoceptor agonist clonidine, the mu-opioid receptor agonists morphine and

267 ed in anesthesia and pain management include clonidine, tizanidine, and dexmedetomidine.

268 there is little difference in the ability of clonidine to interact with or stabilize alpha(2)-AR-Gial

269 The addition of clonidine to intravenous regional anesthesia resulted in

270 no difference in onset time.The addition of clonidine to the local anesthetic opioid mixtures seems

271 Clonidine treatment prevented the further decline in mea

272 ring amphetamine injections and abolished by clonidine treatment.

273 Both EGF and clonidine treatments were associated with a rapid increa

274 a trial was planned to compare midazolam and clonidine, two sedatives widely used within PICUs neithe

275 In another study, the effects of clonidine used for intra-articular administration in com

276 ign to allow separate evaluation of low-dose clonidine versus placebo and low-dose aspirin versus pla

277 son of the dynamics of voltage-dependence of clonidine- vs. norepinephrine-activated receptors uncove

278 owed that co-administration of rapamycin and clonidine was associated with an increased incidence of

279 The protective effect of clonidine was attenuated when the alpha(2)-adrenoceptor

280 These changes were blunted when clonidine was injected intraperitoneally before or after

281 mplete spinalization (T13) was performed and clonidine was injected to induce rhythmic activities.

282 No dose effect of clonidine was observed on gastric emptying.

283 Less clear results were seen when clonidine was used for caudal anesthesia in a pediatric

284 pidural analgesia using levobupivacaine with clonidine was used in patients undergoing total hip arth

285 The higher doses of clonidine were associated with a more cephalad spread of

286 Patients receiving clonidine were more likely than patients receiving place

287 ly, the electrographic responses to NMDA and clonidine were potentiated, whereas the ECoG effects med

288 All of the effects of clonidine were prevented by coadministration of an alpha

289 The effects of clonidine were prevented by the alpha-2A subtype selecti

290 or responses in the leg to phenylephrine and clonidine were similar (or enhanced) postexercise vs. pr

291 esponses in the forearm to phenylephrine and clonidine were similar (or enhanced) postexercise vs. pr

292 for older versus young men, respectively) to clonidine were similar in the 2 groups.

293 ansmission, the effects of noradrenaline and clonidine were tested on the capsaicin-activated current

294 and apraclonidine, acted in a similar way to clonidine when applied topically but because of the numb

295 assessed if the alpha2-autoreceptor agonist clonidine (which decreases norepinephrine release) would

296 Low-dose clonidine, which blunts central sympathetic outflow, may

297 blocked the increased resistance induced by clonidine, while a Gs-protein antagonist was without eff

298 cts were identified for midazolam and 16 for clonidine with full texts obtained for 80 and 6 articles

299 For the comparison of clonidine with placebo, patients were randomly assigned

300 after exposure to forskolin, isoproterenol, clonidine, yohimbine, pertussis toxin, and the NO donor